These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15192321)

  • 1. Subpressor dose asymmetric dimethylarginine modulates renal function in humans through nitric oxide synthase inhibition.
    Kielstein JT; Simmel S; Bode-Böger SM; Roth HJ; Schmidt-Gayk H; Haller H; Fliser D
    Kidney Blood Press Res; 2004; 27(3):143-7. PubMed ID: 15192321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans.
    Kielstein JT; Impraim B; Simmel S; Bode-Böger SM; Tsikas D; Frölich JC; Hoeper MM; Haller H; Fliser D
    Circulation; 2004 Jan; 109(2):172-7. PubMed ID: 14662708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is l-arginine infusion an adequate tool to assess endothelium-dependent vasodilation of the human renal vasculature?
    Schlaich MP; Jacobi J; John S; Delles C; Fleischmann I; Schmieder RE
    Clin Sci (Lond); 2000 Oct; 99(4):293-302. PubMed ID: 10995594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral contraceptives on the nitric oxide system and renal function.
    Cherney DZ; Scholey JW; Cattran DC; Kang AK; Zimpelmann J; Kennedy C; Lai V; Burns KD; Miller JA
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1539-44. PubMed ID: 17715260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects.
    Kielstein JT; Bode-Böger SM; Frölich JC; Ritz E; Haller H; Fliser D
    Circulation; 2003 Apr; 107(14):1891-5. PubMed ID: 12681993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension.
    Patterson ME; Mouton CR; Mullins JJ; Mitchell KD
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F754-9. PubMed ID: 15900020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG; Thiemermann C
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood flow-dependent changes in renal interstitial guanosine 3',5'-cyclic monophosphate in rabbits.
    Nishiyama A; Kimura S; Fukui T; Rahman M; Yoneyama H; Kosaka H; Abe Y
    Am J Physiol Renal Physiol; 2002 Feb; 282(2):F238-44. PubMed ID: 11788437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium-derived nitric oxide modulates renal hemodynamics in the developing piglet.
    Solhaug MJ; Wallace MR; Granger JP
    Pediatr Res; 1993 Dec; 34(6):750-4. PubMed ID: 8108187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure.
    Kielstein JT; Bode-Böger SM; Klein G; Graf S; Haller H; Fliser D
    Eur J Clin Invest; 2003 May; 33(5):370-5. PubMed ID: 12713449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
    Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
    Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
    Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs.
    Egi Y; Matsumura Y; Murata S; Umekawa T; Hisaki K; Takaoka M; Morimoto S
    J Pharmacol Exp Ther; 1994 May; 269(2):529-35. PubMed ID: 7514219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-arginine infusion in normotensive subjects with and without a family history of hypertension.
    Herlitz H; Jungersten LU; Wikstrand J; Widgren BR
    Kidney Int; 1999 Nov; 56(5):1838-45. PubMed ID: 10571792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function in compensated hepatic cirrhosis: effects of an amino acid infusion and relationship with nitric acid.
    Rodriquez A; Martin A; Oterino JA; Blanco I; Jimenez M; Perez A; Novoa JM
    Dig Dis; 1999; 17(4):235-40. PubMed ID: 10754364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.
    Schwedhelm E; Maas R; Freese R; Jung D; Lukacs Z; Jambrecina A; Spickler W; Schulze F; Böger RH
    Br J Clin Pharmacol; 2008 Jan; 65(1):51-9. PubMed ID: 17662090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.